@article{66b3b32d25cc43568d6cc2aa663d7e35,
title = "MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia",
abstract = "Although modern treatment strategies are highly eff ective in many cases of progressive chronic lymphocytic leukemia (CLL), a challenging subgroup of patients show poor response to standard regimens and a survival of less than 2 years [1]. In addition, a proportion of CLL ( ∼ 10\%) undergoes transformation into diff use large B-cell lymphoma, an almost invariably lethal complication known as Richter syndrome (RS) [2,3].",
keywords = "Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia",
author = "\{De Paoli\}, L and Mv Cerri and S Monti and S Rasi and V Spina and A Bruscaggin and M Greco and C Ciardullo and R Fam{\`a} and S Cresta and R Maffei and M Ladetto and Maurizio Martini and Luca Laurenti and F Forconi and R Marasca and Larocca, \{Luigi Maria\} and F Bertoni and G Gaidano and D. Rossi",
year = "2012",
doi = "10.3109/10428194.2012.723706",
language = "English",
pages = "N/A--N/A",
journal = "LEUKEMIA \& LYMPHOMA",
issn = "1042-8194",
publisher = "Taylor \& Francis Limited:Rankine Road, Basingstoke RG24 8PR United Kingdom:011 44 1256 813035, EMAIL:
[email protected],
[email protected], INTERNET: http://www.tandf.co.uk, Fax: 011 44 1256 330245",
}